Clinical Trials: Archive 1996

Nevirapine Trial Confirms Dr. Schooley's Point (December 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
1592: Two Studies Recruiting (November 15, 1996)
In AIDS Treatment News, from AIDS Treatment News
Cytarabine Nixed for PML (November 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Nerve Growth Factor Study Opens (November 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Nelfinavir Expanded Access Program (October, 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Nelfinavir (Viracept™) Expanded Access Announced (September 19, 1996)
In AIDS Treatment News, from AIDS Treatment News
CAESER Study Completed (September 1996)
In Hopkins HIV Report, from Johns Hopkins AIDS Service
1592 -- New Experimental Antiretroviral (August 23, 1996)
In AIDS Treatment News, from AIDS Treatment News
Five-Drug or Six-Drug Antiretroviral Therapy -- Conversation with Steven Scheibel, M.D. (August 23, 1996)
In AIDS Treatment News, from AIDS Treatment News
Nelfinavir Protease Inhibitor Study Recruiting (August 23, 1996)
In AIDS Treatment News, from AIDS Treatment News
Another Call for Strategy Trials (August 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
NAC: First Controlled Trial, Positive Results (July 5, 1996)
In AIDS Treatment News, from AIDS Treatment News
Protease Inhibitors: Ritonavir and Saquinavir Combination Trial Recruiting (April 19, 1996)
In AIDS Treatment News, from AIDS Treatment News
California: Clinical Trials Computer Service Now Available Statewide (April 5, 1996)
In AIDS Treatment News, from AIDS Treatment News
Pediatric Treatment Update (March 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Curcumin Trial Finds No Activity (February 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Hydroxyurea Continues to Show Promise (February 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
New Anti-HIV Vaccine and KS Trials at the National Cancer Institute (February 1996)
By Robert Yarchoan, M.D., Chief, Retroviral Diseases Section, MB, DCS.
From National Cancer Institute
ACTG Oncology Committee Finds New Home at National Cancer Institute, But Funding Is Woefully Inadequate (February 1996)
In TAGline, from Treatment Action Group
The First Integrase Inhibitor (January 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

TheBody.com's App for iPhones
TheBody.com's Medication and Health Reminders
TheBody.com's Facebook, Widgets, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. ASO Finder U.S. ASO Listings
International ASOs

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.